Papers/PMID:34224055
Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study.
Breast cancer research and treatment2021The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
Zn(2+) — no detected effect on breast cancer incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“No overall association was seen between zinc and breast cancer risk.”
Quoted verbatim from Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study.. - Study
- case-control
- Population
- Women in the Malmo Diet and Cancer Study, Sweden: 1186 incident breast cancer cases matched to 1186 controls; zinc taken as baseline serum zinc, dietary zinc intake including supplements, and their combination
Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study.2021PMID:34224055Permalink